HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Namiki Izumi Selected Research

Carcinogenesis

10/2021Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients.
1/2021Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment.
1/2017Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Namiki Izumi Research Topics

Disease

105Hepatocellular Carcinoma (Hepatoma)
11/2022 - 11/2003
67Chronic Hepatitis C
10/2022 - 04/2003
50Infections
10/2022 - 10/2003
39Fibrosis (Cirrhosis)
10/2022 - 12/2003
23Hepatitis C
01/2022 - 09/2003
22Neoplasms (Cancer)
11/2022 - 11/2005
22Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 09/2007
18Chronic Hepatitis B
11/2021 - 12/2003
14Liver Diseases (Liver Disease)
01/2022 - 01/2005
10Disease Progression
05/2022 - 01/2003
8Thrombocytopenia (Thrombopenia)
10/2020 - 09/2011
7Ascites
06/2022 - 02/2015
7Hepatitis B
10/2021 - 01/2011
6Chronic Hepatitis (Chronic Active Hepatitis)
10/2021 - 01/2003
6Hepatitis
09/2021 - 01/2003
5Liver Neoplasms (Liver Cancer)
02/2019 - 01/2013
4Hemorrhage
04/2021 - 01/2016
4Anemia
10/2020 - 09/2011
4Thrombosis (Thrombus)
10/2020 - 02/2018
4Headache (Headaches)
11/2016 - 06/2014
3Non-alcoholic Fatty Liver Disease
02/2022 - 12/2019
3Carcinogenesis
10/2021 - 01/2017
3Fatty Liver
10/2021 - 08/2010
3Neutropenia
10/2020 - 03/2015
3Diarrhea
12/2016 - 06/2014
3Nasopharyngitis
11/2016 - 06/2014
3Neoplasm Metastasis (Metastasis)
10/2015 - 08/2012
2Cholangiocarcinoma
08/2021 - 08/2021
2COVID-19
01/2021 - 01/2020
2Varicose Veins (Varicose Vein)
08/2020 - 03/2020
2Hepatitis E
10/2018 - 01/2010

Drug/Important Bio-Agent (IBA)

51InterferonsIBA
11/2021 - 09/2003
47Ribavirin (Virazole)FDA LinkGeneric
10/2019 - 04/2003
31Antiviral Agents (Antivirals)IBA
07/2022 - 01/2008
25Sorafenib (BAY 43-9006)FDA Link
11/2022 - 09/2010
12Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2006
11AlbuminsIBA
07/2022 - 09/2011
11alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 01/2006
11DNA (Deoxyribonucleic Acid)IBA
10/2021 - 12/2003
10lenvatinibIBA
11/2022 - 06/2019
9wisteria lectinIBA
10/2021 - 09/2015
9Alanine Transaminase (SGPT)IBA
01/2018 - 01/2006
8Fetal Proteins (Fetoprotein)IBA
11/2022 - 01/2011
8SofosbuvirIBA
10/2022 - 11/2014
8Hepatitis B e AntigensIBA
10/2021 - 12/2003
7BilirubinIBA
06/2022 - 07/2009
7Carrier Proteins (Binding Protein)IBA
10/2021 - 12/2018
7Proteins (Proteins, Gene)FDA Link
10/2019 - 11/2005
7Pharmaceutical PreparationsIBA
01/2019 - 12/2004
7RNA (Ribonucleic Acid)IBA
08/2015 - 01/2010
6NucleotidesIBA
10/2021 - 06/2015
6NucleosidesIBA
10/2021 - 01/2005
6AntigensIBA
10/2021 - 09/2002
6tenofovir alafenamideIBA
09/2021 - 11/2016
6lusutrombopagIBA
04/2021 - 01/2019
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018 - 01/2010
6SimeprevirIBA
12/2015 - 05/2014
6Interferon-alpha (Interferon Alfa)IBA
03/2013 - 01/2003
5daclatasvirIBA
05/2022 - 01/2014
5TolvaptanFDA Link
01/2022 - 01/2016
5Transaminases (Aminotransferases)IBA
01/2018 - 01/2006
5CreatinineIBA
11/2016 - 09/2011
4asunaprevirIBA
05/2022 - 06/2014
4acarboxyprothrombin (PIVKA)IBA
01/2022 - 04/2012
4Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2020 - 02/2014
4Tenofovir (Viread)FDA Link
11/2019 - 11/2016
4Tumor Biomarkers (Tumor Markers)IBA
10/2019 - 11/2005
4Amino AcidsFDA Link
01/2017 - 12/2010
4Lamivudine (Epivir)FDA Link
02/2010 - 12/2003
3velpatasvirIBA
10/2022 - 07/2018
3Tyrosine Kinase InhibitorsIBA
05/2022 - 08/2019
3DiureticsIBA
01/2022 - 06/2016
3Carnitine (L-Carnitine)FDA LinkGeneric
11/2020 - 08/2015
3Serum AlbuminIBA
01/2020 - 10/2013
3entecavirFDA Link
01/2020 - 01/2010
3SonazoidIBA
07/2019 - 01/2014
3CollagenIBA
01/2019 - 06/2013
3Therapeutic UsesIBA
02/2018 - 01/2010
3Messenger RNA (mRNA)IBA
01/2017 - 09/2003
2Prothrombin (Factor II)IBA
01/2022 - 01/2011
2Vasopressins (Vasopressin)IBA
01/2022 - 06/2016
2Indicators and Reagents (Reagents)IBA
01/2021 - 02/2018
2Immunoglobulin M (IgM)IBA
01/2021 - 01/2020
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2020
2ProdrugsIBA
11/2019 - 01/2018
2regorafenibIBA
10/2019 - 08/2019
2elbasvirIBA
10/2019 - 01/2019
2Protease Inhibitors (Protease Inhibitor)IBA
10/2019 - 01/2019
2grazoprevirIBA
10/2019 - 01/2019
2glecaprevir and pibrentasvirIBA
10/2019 - 07/2019
2ledipasvirIBA
10/2018 - 06/2015

Therapy/Procedure

103Therapeutics
11/2022 - 01/2003
11Radiofrequency Ablation
01/2022 - 09/2007
5Aftercare (After-Treatment)
01/2022 - 08/2014
5Drug Therapy (Chemotherapy)
01/2022 - 01/2018
5Platelet Transfusion (Blood Platelet Transfusions)
04/2021 - 01/2018
5Liver Transplantation
07/2016 - 09/2007
4Hepatectomy
01/2022 - 01/2020
4Renal Dialysis (Hemodialysis)
07/2019 - 12/2015
3Drug Tapering
09/2011 - 01/2011